You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MPS IIIA

Showing 1 - 25 of 733
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MPS IIIA, Sanfilippo Syndrome, Sanfilippo A Trial in Pittsburgh, North Adelaide, Santiago De Compostela (ABO-102)

Terminated
  • MPS IIIA
  • +3 more
  • Pittsburgh, Pennsylvania
  • +2 more
Jan 11, 2023

Study of Patients With MPS IIIA Treated With ABO-102

Enrolling by invitation
  • Mucopolysaccharidosis III-A
  • ABO-102
  • Columbus, Ohio
  • +2 more
Nov 8, 2022

Sanfilippo Syndrome Type A (MPS IIIA) Trial in Oakland, Chapel Hill, Ankara (SOBI003)

Completed
Has Results
  • Sanfilippo Syndrome Type A (MPS IIIA)
  • Oakland, California
  • +2 more
Feb 2, 2022

Sanfilippo Syndrome Type A (MPS IIIA) Trial in Germany, Turkey, United States (SOBI003)

Completed
Has Results
  • Sanfilippo Syndrome Type A (MPS IIIA)
  • Oakland, California
  • +3 more
Nov 18, 2021

MPS IIIA, Sanfilippo Syndrome, Sanfilippo A Trial in Australia, Spain, United States (ABO-102)

Active, not recruiting
  • MPS IIIA
  • +3 more
  • ABO-102
  • Columbus, Ohio
  • +4 more
Nov 8, 2022

Sanfilippo Syndrome A Trial (assessment)

Not yet recruiting
  • Sanfilippo Syndrome A
  • assessment
  • (no location specified)
Jun 6, 2021

A Study of Patients With Sanfilippo Syndrome Type A (MPS IIIA)

Completed
Has Results
  • Sanfilippo Syndrome Type A
  • assessment
  • Minneapolis, Minnesota
    University of Minnesota
May 19, 2021

Mucopolysaccharidosis Type IIIA Trial in Worldwide (LYS-SAF302)

Active, not recruiting
  • Mucopolysaccharidosis Type IIIA
  • Orange, California
  • +7 more
Aug 30, 2021

Mucopolysaccharidosis Type IIIA Trial in Manchester (Autologous CD34+ cells transduced with a lentiviral vector containing the

Active, not recruiting
  • Mucopolysaccharidosis Type IIIA
  • Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene
  • Manchester, United Kingdom
    Manchester University NHS Foundation Trust
Jul 2, 2021

Mucopolysaccharidosis III-A Trial in Hamburg (JR-441)

Recruiting
  • Mucopolysaccharidosis III-A
  • Hamburg, Germany
    Universitätsklinikum Hamburg-Eppendorf
Oct 18, 2023

Carotid Structure and Function in MPS Syndromes: A Multicenter

Completed
Has Results
  • Mucopolysaccharidoses
    • Orange, California
    • +1 more
    Feb 5, 2021

    Mucopolysaccharidosis Type 3 B Trial in Worldwide (rAAV9.CMV.hNAGLU)

    Terminated
    • Mucopolysaccharidosis Type 3 B
    • rAAV9.CMV.hNAGLU
    • Columbus, Ohio
    • +3 more
    Apr 29, 2022

    Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo)

    Active, not recruiting
    • Mental Retardation
    • Developmental Delay
      • Cairo, Egypt
      • +4 more
      May 12, 2021

      Set for Head, Neck and Respiratory Disease in

      Completed
      • Mucopolysaccharidosis Type II
        • Manchester, Lancashire, United Kingdom
          Manchester University NHS Foundation Trust
        Aug 31, 2023

        MPS (RaDiCo Cohort) (RaDiCo-MPS)

        Recruiting
        • Mucopolysaccharidosis I
        • +7 more
          • Angers, France
          • +22 more
          Sep 12, 2023

          Kidney Transplant Rejection Trial (Enteric-Coated Mycophenolate Sodium (EC-MPS))

          Not yet recruiting
          • Kidney Transplant Rejection
          • Enteric-Coated Mycophenolate Sodium (EC-MPS)
          • (no location specified)
          May 23, 2023

          NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

          Recruiting
          • Non-small Cell Lung Cancer
          • +3 more
          • Yangzhou, Jiangsu, China
            People's hospital of northern jiangsu
          Sep 26, 2023

          MPS-IH (Hurler Syndrome) Trial in Worldwide (Experimental: OTL-203, Active Comparator: Allo-HSCT)

          Not yet recruiting
          • MPS-IH (Hurler Syndrome)
          • Experimental: OTL-203
          • Active Comparator: Allo-HSCT
          • Oakland, California
          • +6 more
          Nov 27, 2023

          Myofascial Pain Syndrome Trial (Myofascial Pain Syndrome Knowledge and Awareness Questionnaire)

          Not yet recruiting
          • Myofascial Pain Syndrome
          • Myofascial Pain Syndrome Knowledge and Awareness Questionnaire
          • (no location specified)
          May 21, 2023

          Mucopolysaccharidosis Type IIIB, MPS III B Trial in Worldwide (AX 250)

          Active, not recruiting
          • Mucopolysaccharidosis Type IIIB
          • MPS III B
          • AX 250
          • Oakland, California
          • +7 more
          Jan 16, 2023

          Prostate Cancer Trial in San Francisco (MyProstateScore 2.0 Results)

          Recruiting
          • Prostate Cancer
          • MyProstateScore 2.0 Results
          • San Francisco, California
            QURE Healthcare
          Jun 15, 2023

          Imaging Biomarkers for Myofascial Pain

          Enrolling by invitation
          • Myofascial Pain Syndrome
          • Healthy
          • Ultrasound imaging
          • +3 more
          • Fairfax, Virginia
            George Mason University
          Sep 27, 2023

          Myofascial Pain Syndrome of Neck Trial in New Taipei City (Surface electrical stimulation (SES), Remote medical support)

          Recruiting
          • Myofascial Pain Syndrome of Neck
          • Surface electrical stimulation (SES)
          • Remote medical support
          • New Taipei City, Taiwan
            WanFang Hospital
          Aug 4, 2023

          Mucopolysaccharidosis II Trial in Japan (JR-141)

          Completed
          • Mucopolysaccharidosis II
          • Gifu, Japan
          • +7 more
          Nov 10, 2022

          Mucopolysaccharidosis I Trial in Wuhan (Laronidase)

          Recruiting
          • Mucopolysaccharidosis I
          • Wuhan, China
            Investigational Site Number :1560001
          Jan 15, 2023